Ceapro Income Statement

Health Care & Life Sciences » Biotechnology | Ceapro Inc.

Ceapro Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.

2013

2014

2015

2016

2017

2018

Sales/Revenue

6,524.10

8,890.30

10,667.40

13,674.00

12,925.80

11,592.70

Cost of Goods Sold (COGS) incl. D&A

3,486.40

4,212.80

3,815.90

4,462.80

5,797.50

5,724.50

Gross Income

3,037.70

4,677.40

6,851.50

9,211.20

7,128.30

5,868.10

SG&A Expense

2,464.00

2,489.80

2,974.90

2,969.00

4,335.20

5,621.30

EBIT

573.70

2,187.70

3,876.60

6,242.20

639.40

246.80

Unusual Expense

240.10

449.90

356.90

572.40

658.90

494.20

Non Operating Income/Expense

53.60

80.50

92.40

113.70

325.80

610.10

Interest Expense

104.20

63.50

196.60

192.90

81.60

63.70

Pretax Income

175.80

1,593.80

3,230.70

5,363.30

426.80

921.20

Income Tax

1,691.40

1,743.40

531.50

605.70

Consolidated Net Income

175.80

1,593.80

4,922.20

3,619.90

958.30

315.50

Net Income

175.80

1,593.80

4,922.20

3,619.90

958.30

315.50

Net Income After Extraordinaries

175.80

1,593.80

4,922.20

3,619.90

958.30

315.50

Net Income Available to Common

175.80

1,593.80

4,922.20

3,619.90

958.30

315.50

EPS (Basic)

0.00

0.03

0.08

0.05

0.01

Basic Shares Outstanding

60,278.90

60,901.60

61,804.30

67,684.80

75,343.90

76,201.20

EPS (Diluted)

0.00

0.03

0.08

0.05

0.01

Diluted Shares Outstanding

60,278.90

60,901.60

65,200.00

71,329.20

75,343.90

76,201.20

EBITDA

866.30

2,484.10

4,269.00

6,601.60

965.50

825.40

Other Operating Expense

2,153.60

About Ceapro

View Profile

Address	7824-51 Avenue NW Edmonton Alberta T6E 6W2 Canada
Employees	-
Website	http://www.ceapro.com
Updated	07/08/2019
Ceapro, Inc. is a biotechnology company, which is involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its extracts are also used in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The company specializes in natural product chemistry, microbiology, biochemistry, immunology, and process engineering in the fields of active ingredients, biopharmaceuticals, and drug-delivery solutions.

Ceapro Inc. | Income Statement

About Ceapro

StatInvestor